Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
Open Access
- 1 October 2008
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 49 (10) , 2101-2112
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Cardiomyocyte expression of PPARγ leads to cardiac dysfunction in miceJournal of Clinical Investigation, 2007
- TLR4 links innate immunity and fatty acid–induced insulin resistanceJournal of Clinical Investigation, 2006
- The prevention and treatment of metabolic syndrome and high-risk obesityCurrent Opinion in Cardiology, 2006
- Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in miceBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- Glycogen depletion in intrafusal fibres in rats during short-duration high-intensity treadmill runningActa Physiologica Scandinavica, 2005
- Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failureJournal of Clinical Investigation, 2005
- A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty AcidsJournal of Biological Chemistry, 2003
- De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma CellsJournal of Biological Chemistry, 2002
- Mechanisms of LipoapoptosisTrends in Cardiovascular Medicine, 2002
- Sodium Palmitate Induces Partial Mitochondrial Uncoupling and Reactive Oxygen Species in Rat Pancreatic Islets in VitroEndocrinology, 1999